SlideShare a Scribd company logo
IIMT College of Pharmacy, Greater Noida
Antibiotic
Ms. Bharti Chauhan
(ASSISTANT
PROFESSOR)
Unit: I
Subject Name- Medicinal Chemistry-III
BP-601T
B Pharm VI Sem
UNIT – I
Antibiotic 08 Hours
Antibiotics Historical background, Nomenclature, Stereochemistry,
Structure activity relationship, Chemical degradation classification and
important products of the following classes.
β-Lactam antibiotics: Penicillin, Cepholosporins, β- Lactamase
inhibitors, Monobactams
Aminoglycosides: Streptomycin, Neomycin, Kanamycin Tetracyclines:
Tetracycline, Oxytetracycline, Chlortetracycline, Minocycline,
Doxycycline
SYLLABUS
• Introduction
• Introduction of antibiotics.
• Classification and mode of action β-Lactam antibiotics
• Introduction of synthetic antifungal agents
• Classification and mode of Penicillin, Cepholosporins, β- Lactamase
inhibitors, Monobactams
• Structure activity relationship of β-Lactam antibiotics
• Introduction of Aminoglycosides: Streptomycin, Neomycin,
Kanamycin Tetracyclines.
• Tetracycline, Oxytetracycline, Chlortetracycline, Minocycline,
Doxycycline
3
CONTENT
Upon completion of the course student shall be able to
1. Understand the importance of drug design and different techniques
of drug design.
2. Understand the chemistry of drugs with respect to their biological
activity.
3. Know the metabolism, adverse effects and therapeutic value of
drugs.
4. Know the importance of SAR of drugs.
4
COURSE OBJECTIVE
5
COURSE OUTCOME
CO No. CO STATEMENT LEVEL OF TAXONOMY
CO1.1 History and Different types of
antibiotics.
Level I
(Remembering)
CO1.2 Mode and action and structure
activity relationship of β-Lactam
antibiotics
Level II
(Understanding)
CO1.3 Use and adverse effect of β-
Lactam antibiotics .
Level III
(Applying)
After completion of this unit it is expected that students will be able to
6
PROGRAMME OUTCOMES (POs)
PO 1 Pharmacy Knowledge: Possess knowledge and comprehension of the core
and basic knowledge associated with the profession of pharmacy,
including biomedical sciences; pharmaceutical sciences; behavioral,
social, and administrative pharmacy sciences; and manufacturing
practices.
PO 2 Planning Abilities: Demonstrate effective planning abilities including time
management, resource management, delegation skills and organizational
skills. Develop and implement plans and organize work to meet deadlines
PO 3 Problem analysis: Utilize the principles of scientific enquiry, thinking
analytically, clearly and critically, while solving problems and making
decisions during daily practice. Find, analyze, evaluate and apply
information systematically and shall make defensible decisions.
PO 4 Modern tool usage: Learn, select, and apply appropriate methods and
procedures, resources, and modern pharmacy-related computing tools
with an understanding of the limitations.
7
PROGRAMME OUTCOMES (POs)
PO 5 Leadership skills: Understand and consider the human reaction to change,
motivation issues, leadership and team-building when planning changes
required for fulfillment of practice, professional and societal
responsibilities. Assume participatory roles as responsible citizens or
leadership roles when appropriate to facilitate improvement in health
and wellbeing.
PO 6 Professional Identity: Understand, analyze and communicate the value of
their professional roles in society (e.g. health care professionals, promoters
of health, educators, managers, employers, employees).
PO 7 Pharmaceutical Ethics: Honour personal values and apply ethical principles
in professional and social contexts. Demonstrate behavior that recognizes
cultural and personal variability in values, communication and lifestyles.
Use ethical frameworks; apply ethical principles while making decisions
and take responsibility for the outcomes associated with the decisions.
8
PROGRAMME OUTCOMES (POs)
PO 8 Communication: Communicate effectively with the pharmacy community
and with society at large, such as, being able to comprehend and write
effective reports, make effective presentations and documentation, and
give and receive clear instructions.
PO 9 The Pharmacist and society: Apply reasoning informed by the contextual
knowledge to assess societal, health, safety and legal issues and the
consequent responsibilities relevant to the professional pharmacy practice
PO 10 Environment and sustainability: Understand the impact of the professional
pharmacy solutions in societal and environmental contexts, and
demonstrate the knowledge of, and need for sustainable development
PO 11 Life-long learning: Recognize the need for, and have the preparation and
ability to engage in independent and life-long learning in the broadest
context of technological change. Self access and use feedback effectively
from others to identify learning needs and to satisfy these needs on an
ongoing basis.
9
CO-PO MAPPING
The CO-PO mapping has been done with correlation levels of 3, 2, 1 and
‘-‘. The notation of 3, 2 and 1 denotes substantially (high), moderately
(medium) and slightly (low). The meaning of ‘-‘is no correlation between
CO and PO.
PO PO
1
PO
2
PO3 PO
4
PO
5
PO6 PO7 PO8 PO9 PO
10
PO
11
CO1.1 3 - 1 3 - - - - 1 - -
CO1.2 3 - 1 3 - - - - 1 - -
CO1.3 3 - 1 3 - - - - 1 - -
10
Topic Objective mapping with CO
Name of Topic Objective of topic Mapping with
CO
Antibiotic
β-Lactam antibiotics
Aminoglycosides
Tetracycline,
Introduction, Mechanism Of Action of
β-Lactam antibiotics
Aminoglycosides
Tetracycline Antibiotic
CO1.1
Classificaion Classify the β-Lactam antibiotics
Aminoglycosides
Tetracycline Antibiotic
CO1.2
Synthesis and SAR Structure activity relationship and
Synthesis of
β-Lactam antibiotics
Aminoglycosides
Tetracycline Antibiotic
CO1.3
• Mapping of Course Outcomes with Topic:
• Subject covers pharmacology of various diseases and chemistry of
drugs along with SAR and their uses.
• Student must have the knowledge of pharmacology of discussed
diseases before going to chemistry of drugs used for the same.
11
ANTIBIOTICS (CO-1.1)
Antibiotic:
Substances derived from a microorganism or produced synthetically,
that destroys or limits the growth of a living organism
 A drug used to treat bacterial infections.
 Antibiotics have no effect on viral infections.
 Originally, an antibiotic was a substance produced by one
microorganism that selectively inhibits the growth of another.
 Synthetic antibiotics, usually chemically related to natural antibiotics,
have since been produced that accomplish comparable tasks.
12
ANTIBIOTICS (CO-1.1)
Classification of antibiotics
• Sources
1. Natural
a. Fungi – penicillin, griseofulvin
b. Bacteria – Bacillus sp. (polymixin, bacitracin) ;
Actinomycetes (tetracycline, chloramphenicol,
streptomycin)
2. Synthetic
13
ANTIBIOTICS (CO-1)
15
ANTIBIOTICS (CO-1.1)
History of Antibiotics (continue ..)
• Antibiotics have been used for millennia to treat infections, although
until the last century or so people did not know the infections were
caused by bacteria
• Various molds and plant extracts were used to treat infections by some
of the earliest civilizations – the ancient Egyptians, for example,
applied moldy bread to infected wounds
• It wasn’t until the late 19th century that scientists began to observe
antibacterial chemicals in action. Paul Ehrlich, a German physician,
noted that certain chemical dyes colored some bacterial cells but not
others. He concluded that, according to this principle, it must be
possible to create substances that can kill certain bacteria selectively
without harming other cells
15
ANTIBIOTICS (CO-1.1)
History of Antibiotics (continue ..)
• In 1909, he discovered that a chemical called arsphenamine was an
effective treatment for syphilis.
• This became the first modern antibiotic, although Ehrlich himself
referred to his discovery as 'chemotherapy' – the use of a chemical to
treat a disease
• The word 'antibiotics' was first used over 30 years later by the
Ukrainian-American inventor and microbiologist Selman Waksman,
who in his lifetime discovered over 20 antibiotics.
15
ANTIBIOTICS (CO-1.1)
History of Antibiotics (continue ..)
• Alexander Fleming was, it seems, a bit disorderly in his work and
accidentally discovered penicillin.
• Upon returning from a holiday in Suffolk in 1928, he noticed that a
fungus, Penicillium notatum, had contaminated a culture plate
of Staphylococcus bacteria he had accidentally left uncovered.
• The fungus had created bacteria-free zones wherever it grew on the
plate.
• Fleming isolated and grew the mold in pure culture.
• He found that P. notatum proved extremely effective even at very low
concentrations, preventing Staphylococcus growth even when diluted
800 times, and was less toxic than the disinfectants used at the time..
15
ANTIBIOTICS (CO-1.1)
• After early trials in treating human wounds, collaborations with
British pharmaceutical companies ensured that the mass production of
penicillin (the antibiotic chemical produced by P. notatum) was
possible.
• Following a fire in Boston, Massachusetts, USA, in which nearly 500
people died, many survivors received skin grafts which are liable to
infection by Staphylococcus.
• Treatment with penicillin was hugely successful, and the US
government began supporting the mass production of the drug.
• By D-Day in 1944, penicillin was being widely used to treat troops
for infections both in the field and in hospitals throughout Europe. By
the end of World War II, penicillin was nicknamed 'the wonder drug'
and had saved many lives.
Difference between the bactericidal and bacteriostatic
 Tetracyclines
 Spectinomycin
 Sulphonamides
 Macrolides
 Chloramphenicol
 Trimethoprim
Bactericidal Antibiotics
 Penicillins
 Cephalosporins •
 Fluoroquinolones
(Ciprofloxacin) •
 Glycopeptides
(Vancomycin) •
 Monobactams
 Carbapenems
16
ANTIBIOTICS (CO-1.1)
Bacteriostatic Antibiotics
16
ANTIBIOTICS (CO-1.2)
Classifications of antibiotics
16
ANTIBIOTICS (CO-1.2)
Classifications of antibiotics
16
ANTIBIOTICS (CO-1.2)
Classifications of antibiotics
16
ANTIBIOTICS (CO-1.2)
Classifications of antibiotics
16
ANTIBIOTICS (CO-1.2)
Classifications of antibiotics
16
ANTIBIOTICS (CO-1.2)
Classifications of antibiotics
Mode action of antibiotics
16
ANTIBIOTICS (CO-1.1)
Inhibitors of DNA synthesis
Inhibitors of bacterial protein synthesis
Inhibitors of bacterial cell wall synthesis
Interference with metabolism
Impairment of nucleic acids
16
ANTIBIOTICS (CO-1)
Inhibitors of DNA synthesis
Inhibitors of bacterial protein synthesis
Inhibitors of bacterial cell wall synthesis
Interference with metabolism
Impairment of nucleic acids
16
ANTIBIOTICS (CO-1)
16
ANTIBIOTICS (CO-1)
16
ANTIBIOTICS (CO-1)
16
ANTIBIOTICS (CO-1.1)
16
ANTIBIOTICS(CO-1.2)
16
ANTIBIOTICS (CO-1.1)
16
ANTIBIOTICS (CO-1.2)
β-lactam antibiotics (beta-lactam antibiotics) are antibiotics that
contain a beta-lactam ring in their molecular structure.
This includes penicillin derivatives
(penams), cephalosporins (cephems), monobactams, carbapenems and
carbacephe
16
ANTIBIOTICS (CO-1.1)
Penicillin
16
ANTIBIOTICS (CO-1)
Penicillin is a secondary metabolite produced by certain bacteria,
which is used an antibiotic .
A bacterial infection is caused by millions of tiny bacteria that are
trying to survive and in multiply the body . An antibiotic attacks and
kill these bacteria .
 Before the development of penicillin , many people suffered and
died from bacterial infections that are no longer considered
dangerous today
16
ANTIBIOTICS (CO-1.1)
HISTORY
1928 – ALEXANDER FLEMING Bread mold (Penicillium notatum)
growing on petri dish
1939 – FLOREY , Chain, and Associates Began work on isolating
and synthesizing large amounts of penicillin.
1941 – Introduced in antibacterial therapy
1944 – penicillin has been at the disposal of all people
History ALEXANDER FLEMING
PROPERTIES
Optically active
Soluble in water.
 Acid resistant.
Hydrolyzed by hot inorganic acid .
 Effective in treatment of respiratory track infection .
16
ANTIBIOTICS (CO-1.1)
Clasification
1.Natural penicillin's
 penicillin G
Penicillin VK
2.Beta lactase resistant penicillin's
3.Aminopenicillins penicillin G Penicillin VK Methicillin nafcillin
Ampicillin amoxicillin
4.Carboxypenicillins
5.Ureidopenicillins
6.penicillin/inihibitor combination Carcenicillin ticarcillin
Mezlocillin piperacillin Ampicillin/sulbactam Ticarcillin/clavulanate
16
ANTIBIOTICS (CO-1.1)
16
ANTIBIOTICS (CO-1.1)
16
ANTIBIOTICS (CO-1)
PenicillinV (Phenoxymethylpenicillin)
Effective Against: • Gram positive + Less
effective against Gram negative bacteria
Treatment For: • Tonsillitis • Anthrax •
Rheumatic fever • Streptococcal skin infections
Characteristics: • Narrow spectrum • Should be
given orally • Prone to beta-lactamase
Penicillin G (Benzylpenicillin)
Narrow spectrum antibiotic.
Primarily to gram positive bacteria and few
others, active agains, Cocci-Streptococci
(except group D), Staph.aureus ; gram
negative N.gonorrheoe and
16
ANTIBIOTICS (CO-1.1)
What is the difference between penicillin G and penicillin V?
Penicillin G is a natural penicillin that is produced directly from
fermentation of Penicillium crysogenum. Penicillin V is a
derivative of penicillin G and because of similarities in spectrum
of activity, is considered a natural penicillin.
Penicillin G benzathine, potassium, procaine and sodium are
currently available in the United States in parenteral
formulations for intravenous or intramuscular use. Penicillin
V potassium (also called phenoxymethyl penicillin) is a more
acid stable and can be administered orally.
16
ANTIBIOTICS (CO-1.1)
ANTIBIOTICS (CO-1.1)
ANTIBIOTICS (CO-1.1)
ANTIBIOTICS (CO-1.1)
ANTIBIOTICS (CO-1.1)
ANTIBIOTICS (CO-1.1)
ANTIBIOTICS (CO-1.1)
ANTIBIOTICS (CO-1.1)
ANTIBIOTICS (CO-1.1)
ANTIBIOTICS (CO-1.1)
ANTIBIOTICS (CO-1.1)
ANTIBIOTICS (CO-1.1)
ANTIBIOTICS (CO-1.1)
SAR OF PENICILLI
ANTIBIOTICS (CO-1.3)
SAR OF PENICILLI
5/8/2024 Chandana majee BP-601T Med.Chem-III Unit-1 16
ANTIBIOTICS (CO-1.1)
SAR OF PENICILLI
ANTIBIOTICS (CO-1.3)
ANTIBIOTICS (CO-1.3)
ANTIBIOTICS (CO-1.3)
MECHANISM OF ACTION OF PENICILLIN
Penicillin and other antibiotics in the beta-lactam family contain a characteristic four-membered
beta-lactam ring. Penicillin kills bacteria through binding of the beta-lactam ring to DD-
transpeptidase, inhibiting its cross-linking activity and preventing new cell wall formation.
Without a cell wall, a bacterial cell is vulnerable to outside water and molecular pressures,
which causes the cell to quickly die. Since human cells do not contain a cell wall, penicillin
treatment results in bacterial cell death without affecting human cells.
Gram-positive bacteria have thick cell walls containing high levels of peptidoglycan, while gram-
negative bacteria are characterized by thinner cell walls with low levels of peptidoglycan. The
cell walls of gram-negative bacteria are surrounded by a lipopolysaccharide (LPS) layer that
prevents antibiotic entry into the cell. Therefore, penicillin is most effective against gram-
positive bacteria where DD-transpeptidase activity is highest.
ANTIBIOTICS (CO-1.3)
Nomenclature
(a) There are two types of numbering for the fused bicycling system of
penicillin: whether which atom is number one Sulfur or Nitrogen.
(b) Penam nucleus is used in naming which comprise bicyclic system
with the amide carbonyl group. Penicillin is named as 6-acylamino-
2,2-dimethylpenam-3-carboxylic acid.
(c) Penicillanic acid nucleus: Which includes the 2,2-dimethyl and 3-
carboxyl groups. Penicillin is named as 6- carbonylaminopenicillanic
acid.
(d) Penicillin nucleus: Which includes 6-carbonyl aminopenicillanic acid.
So Penicillin G is named benzylpenicillin if R is benzene ring
ANTIBIOTICS (CO-1.3)
ANTIBIOTICS (CO-1.3)
ANTIBIOTICS (CO-1.3)
ANTIBIOTICS (CO-1.3)
ANTIBIOTICS (CO-1.3)
ANTIBIOTICS (CO-1.3)
Nomenclature
ANTIBIOTICS (CO-1.3)
Stereochemistry
(a) The penicillin molecule contains three chiral carbon atoms at C-3, C-5 and
C-6
(b) All natural and synthetic penicillins have the same absolute configuration
about these three centers
(c) The 6 carbon atom bearing the acyl amino group has the L-configuration,
whereas the carbon to which the carboxyl group was attached has the D-
configuration.
(d) The acyl amino group and carboxyl group are trans to each other, with the
former and latter in the β orientation relative to penam ring.
(e) The absolute stereochemistry of the penicillins is designated as 35: 5R: 6R.
(f) The atoms composing the 6-aminopenicillanic acid are biosynthetically
derived from two amino acids, Lcysteine and D-valine
ANTIBIOTICS (CO-1.3)
ANTIBIOTICS (CO-1.3)
16
ANTIBIOTICS (CO-1.3)
16
ANTIBIOTICS (CO-1.3)
16
ANTIBIOTICS (CO-1.3)
16
ANTIBIOTICS (CO-1.3)
16
ANTIBIOTICS (CO-1.3)
16
ANTIBIOTICS (CO-1.3)
16
ANTIBIOTICS (CO-1.1)
Mechanism of action penicillinen
ANTIBIOTICS (CO-1)
16
ANTIBIOTICS (CO-1)
16
ANTIBIOTICS (CO-1.1)
β- Lactamase enzyme
Beta-lactamases are enzymes produced by bacteria that
provide multi- resistance to β-lactam antibiotics such
as penicillins, cephalosporins, cephamycins,
and carbapenems (ertapenem), although carbapenems are
relatively resistant to beta-lactamase.
In Gram-negative bacteria, β-lactamase enzymes that hydrolyze
the amide bond of the four-membered β-lactam ring are the
primary resistance mechanism,
16
ANTIBIOTICS (CO-1.1)
β- Lactamase inhibitors:
Beta-lactamases are a family of enzymes involved in
bacterial resistance to beta-lacta antibiotics. They act by breaking
the beta-lactam ring that allows penicillin-like antibiotics to work.
Beta-lactamase enzymes are produced by certain strains of the
followingbacteria: Bacteroides species, Enterococcus species, Hemo
philus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae,
and Staphylococcus species, either constitutively or on exposure to
antimicrobials.
Beta-lactamases cleave the beta-lactam ring of susceptible
penicillins and cephalosporins, inactivating the antibiotic. Some
antimicrobials (eg, cefazolin and cloxacillin) are naturally resistant
to certain beta-lactamases.
16
ANTIBIOTICS (CO-1.1)
β- Lactamase inhibitors:
Clavulanic acid contains a beta-lactam ring and binds strongly to
beta-lactamase at or near its active site, thereby hindering
enzymatic activity. This protects other beta-lactam antibiotics from
beta-lactamase catalysis, thereby enhancing their antibacterial
effects.
Chandana majee BP-601T Med.Chem-III Unit-1 16
ANTIBIOTICS (CO-1.1)
5/8/2024
β- Lactamase inhibitors:
Clavulanic acid contains a beta-lactam ring and binds strongly to
beta-lactamase at or near its active site, thereby hindering
enzymatic activity. This protects other beta-lactam antibiotics from
beta-lactamase catalysis, thereby enhancing their antibacterial
effects.
Chandana majee BP-601T Med.Chem-III Unit-1 16
ANTIBIOTICS (CO-1.1)
5/8/2024
β- Lactamase inhibitors:
Clavulanic acid contains a beta-lactam ring and binds strongly to
beta-lactamase at or near its active site, thereby hindering
enzymatic activity. This protects other beta-lactam antibiotics from
beta-lactamase catalysis, thereby enhancing their antibacterial
effects.
16
ANTIBIOTICS (CO-1.1)
β- Lactamase inhibitors:
Clavulanic acid contains a beta-lactam ring and binds strongly to
beta-lactamase at or near its active site, thereby hindering
enzymatic activity. This protects other beta-lactam antibiotics from
beta-lactamase catalysis, thereby enhancing their antibacterial
effects.
16
ANTIBIOTICS (CO-1.1)
β- Lactamase inhibitors:
Clavulanic acid contains a beta-lactam ring and binds strongly to
beta-lactamase at or near its active site, thereby hindering
enzymatic activity. This protects other beta-lactam antibiotics from
beta-lactamase catalysis, thereby enhancing their antibacterial
effects.
16
ANTIBIOTICS (CO-1.1)
Clavulanic acid
Clavulanic Acid is a semisynthetic beta-
lactamase inhibitor isolated from
Streptomyces. Clavulanic acid contains a
beta-lactam ring and binds strongly to beta-
lactamase at or near its active site, thereby
hindering enzymatic activit :
.
16
ANTIBIOTICS (CO-1.1)
Clavulanic acid
Clavulanic Acid is a semisynthetic beta-
lactamase inhibitor isolated from
Streptomyces. Clavulanic acid contains a
beta-lactam ring and inds strongly to beta-
lactamase at or near its active site, thereby
hindering enzymatic activit :
.
16
ANTIBIOTICS (CO-1.1)
Clavulanic acid
The combination of amoxicillin
and clavulanic acid is used to treat certain
infections caused by bacteria, including
infections of the ears, lungs, sinus, skin, and
urinary tract. Amoxicillin is in a class of
medications called penicillin-like antibiotics. It
works by stopping the growth of bacteria.
.
16
ANTIBIOTICS (CO-1.2)
β- Lactamase inhibitors
Bactericidal Act by acylation
Clavulanic acid,
sulbactam,
and tazobactam
Avibactam,
vaborbactam,
and relebactam
16
ANTIBIOTICS (CO-1.1)
16
ANTIBIOTICS (CO-1.1)
16
ANTIBIOTICS (CO-1.1)
16
ANTIBIOTICS (CO-1.1)
16
β-LACTAM ANTIBIOTICS
(PENICILLI) (CO-1.1)
16
β-LACTAM ANTIBIOTICS (CO-1.1)
• The cephalosporins were isolated from the fungus Cephalosporium
acremonium in 1948 by Pro Tzu, Newton, and Abraham (1953)
• Cephalosporins contain dihydrothiazine ring, while penicillin contains
a tetrahydrothiazole (thiazolidine) ring
• The cephalosporins are much more acid stable than the corresponding
penicillins.
• Cephalosporins can be divided into three classes:
1. Cephalosporin N: penicillin-like structure - a derivative of 6-
aminopenicillanic acid.
2. Cephalosporin P: An acidic antibiotic, which is steroidal in nature
3. Cephalosporin-C: It is a true cephalosporin and it is a derivative of 7
amino-cephalosporanic acid – semi synthetic derivatives
Cephalosporins
16
β-LACTAM ANTIBIOTICS (CO-1.1)
Cephalosporins
• Cepham is the name given to the unsubstituted
bicyclic lactam.
16
β-LACTAM ANTIBIOTICS (CO-1.1)
Classification Cephalosporins
(Route of administration)
a. Orally administered: cephalexin, cephradine, and cefaclor
b. Parentrally administered: cephalothin, cephapirin, cephacetrile, and
cefazedone. These agents are sensitive to β-lactamase
c. Resistant to β-lactamase and parentrally administered: cefuroxime,
cefamandole, cefoxitin
d. Metabolically unstable: cephalothin and cephapirin
16
β-LACTAM ANTIBIOTICS (CO-1.1)
• First generation cephalosporins - Cephalexin, cephadroxil,
cephradine and cephalothine
• Second-generation cephalosporins - Cefaclor, cefamandole
• Third-generation cephalosporins – Cefotaxime, ceftizoxime
• Fourth generation – Cefepime, Cefpirome
16
β-LACTAM ANTIBIOTICS (CO-1.1)
Degradation of cephalosporins
In prescence of strong acids - inactive lactone
16
β-LACTAM ANTIBIOTICS (CO-1.1)
SAR of cephalosporins
1. 7-Acylamino substituents:
(i) Acylation of amino group generally increases the potency against gram-
positive bacteria, but decreases gram-negative potency.
(ii) Substituents on the aromatic ring that increases lipophilicity provide higher
gram- positive activity and generally lower gram-negative activity.
(iii) The phenyl ring in the side-chain can be replaced with other heterocycles
with improved spectrum of activity and pharmacokinetic properties, and
these include thiophene, tetrazole, furan, pyridine
16
β-LACTAM ANTIBIOTICS (CO-1.1)
SAR of cephalosporins
• 2. C-3 substituents:
• influences pharmacokinetic and pharmacological properties as well as
antibacterial activity. Modification at C-3 position has been made to reduce the
degradation of cephalosporins.
(i) The benzoyl ester - improved gram-positive activity but lower gram-negative
activity.
(ii) Pyridine and imidazole- show improved activity against P. aeruginosa.
• azide ion with relatively low gram-negative activity.
(iii) aromatic thiols of 3-acetoxy group results in an enhancement of activity against
gram-negative bacteria with improved pharmacokinetic properties.
(iv) Replacement of acetoxy group at C-3 position with —CH3, Cl has resulted in
orally active compounds.
16
β-LACTAM ANTIBIOTICS (CO-1.1)
SAR of cephalosporins
3. Introduction of C-7 α-methoxy group shows higher resistance to hydrolysis by
β-lactamases
4. Oxidation of ring sulphur to sulphoxide or sulphone greatly diminishes or
destroys the antibacterial activity.
5. Replacement of sulphur with oxygen leads to oxacepam with increased
antibacterial activity, with methylene group - greater chemical stability and a
longer half-life.
6. The carboxyl group of position-4 has been converted into ester prodrugs to
increase bioavailability of cephalosporins, and these can be given orally as well.
Examples include cefuroxime axetil and cefodoxime proxetil.
7. Olefinic linkage at C 3-4 is essential for antibacterial activity. Isomerization of
the double bond to 2-3 position leads to great losses in antibacterial activity
16
β-LACTAM ANTIBIOTICS (CO-1.1)
Nomenclature of cephalosporins
a) The chemical nomenclature of the cephalosporins is slightly more
complex than even that of the penicillins because of the presence
of a double bond in the dihydrothiazine ring.
b) The fused ring system is designated by Chemical Abstracts as 5-
thia-1-azabicyclo[4.2.0]oct-2-ene.
c) In this system, cephalothin is 3-(acetoxymethyl)-7-[2-
(thienylacetyl)amino]-8-oxo-5-thia-1- azabicyclo[4.2.0]oct-2-ene-
2-carboxylic acid.
16
β-LACTAM ANTIBIOTICS (CO-1.1)
Monobactams
Monobactams are monocyclic and bacterially-produced β-lactam
antibiotics. The β-lactam ring is not fused to another ring, in
contrast to most other β-lactams. Monobactams are effective only
against aerobic Gram-negative bacteria (e.g., Neisseria,
Pseudomonas)
16
ANTIBIOTICS (CO-1.1)
16
ANTIBIOTICS (CO-1.1)
Monobactams
They are resistant to β-lactamases and active against aerobic gram-
negative rods.
They have no activity against gram-positive bacteria or anaerobes.
Aztreonam is the only commercially available monobactam.
It is administered either IV or IM and can accumulate in patients with
renal failure.
Relatively nontoxic, but it may cause phlebitis, skin rash, and,
occasionally, abnormal liver function tests.
Penicillin-allergic patients tolerate aztreonam without reaction.
Monobactams have monocyclic beta lactam ring and are resistant to
beta lactamse
Aminoglycosides
Aminoglycosides are a class of antibiotics used to treat serious
infections caused by bacteria that either multiply very quickly
or are difficult to treat. Aminoglycosides are called
bactericidal antibiotics because they kill bacteria directly.
16
ANTIBIOTICS (CO-1.1)
Aminoglycosides
Aminoglycosides display concentration-dependent bactericidal
activity against "most gram-negative aerobic and facultative
anaerobic bacilli" but not against gram-negative anaerobes and
most gram-positive bacteria. They require only short contact
time and are most effective against susceptible bacterial
populations that are rapidly multiplying.
16
ANTIBIOTICS (CO-1.1)
NH2
N
H2
16
ANTIBIOTICS (CO-1)
SAR OF AMINIGLYCOSIDE
16
ANTIBIOTICS (CO-1)
SAR OF AMINIGLYCOSIDE
16
ANTIBIOTICS (CO-1)
6 amino group
increses the activity
6 amino group replace by OH
decreases the activity
2 amino group
increses the activity
1
2
Acetylating retain the activity
SAR OF AMINIGLYCOSIDE
16
ANTIBIOTICS (CO-1.1)
1
2
16
ANTIBIOTICS (CO-1.1)
AMINOGYCOSIDE
AMINO + GYCOSIDE Polybasic amino groups linked
glycosidically to two or more aminosugar.
16
ANTIBIOTICS (CO-1.1)
Amino Glycoside MOA
16
ANTIBIOTICS (CO-1.1)
Amino Glycoside MOA
16
ANTIBIOTICS (CO-1.1)
Amino Glycoside MOA
16
ANTIBIOTICS (CO-1.3)
Aminogycoside are polar so they can not penetrate the peptidoglycan layer
Amino glycoside
Amino glycoside
ANTIBIOTICS (CO-1.3)
Aminogycoside are polar so they can not penetrate the peptidoglycan layer
Amino glycoside
Amino glycoside
Streptomycin
Streptomycin is an antibiotic medication used to treat a
number of bacterial infections
Streptomycin was discovered in 1943 by Albert Schatz
from Streptomyces griseus. It is on the World Health
Organization's List of Essential Medicines.
16
ANTIBIOTICS (CO-1.1)
Streptomycin
5/8/2024
Chandana majee BP-601T
Med.Chem-III Unit-1
16
ANTIBIOTICS (CO-1.3)
O
O
OH
OH
N
NH
H2N
HO
N
H2N
NH2
O
O OH
OH
OH
HN
O
OH
N Methyl –L-
glucosamine
L -sterptose
Streptidine
Streptomycin
Streptomycin is an antibiotic medication used to treat a
number of bacterial infections
Streptomycin was discovered in 1943 by Albert Schatz
from Streptomyces griseus. It is on the World Health
Organization's List of Essential Medicines.
16
ANTIBIOTICS (CO-1.1)
Streptomycin
• Streptomycin, like other aminoglycosidic antibiotics (e.g.,
gentamycin, neomycin, kanamycin, tobramycin), inhibits
protein synthesis in bacterial cells by binding to the 30S
subunit of ribosomes.
• By doing so, the streptomycin causes a structural change
which interferes with the recognition site of codon-anticodon
interaction resulting in misreading of the genetic message
carried by messenger RNA (mRNA). The mechanism of
inhibition of protein synthesis by streptomycin is
schematically shown in
16
ANTIBIOTICS (CO-1.1)
Streptomycin MOA
16
ANTIBIOTICS (CO-1.1)
Streptomycin
 Infective endocarditis caused by enterococcus when the
organism is not sensitive to gentamicin
 Tuberculosis in combination with other antibiotics. For active
tuberculosis it is often given together with isoniazid,
rifampicin, and pyrazinamide.
 It may be useful in cases where resistance to other drugs is
identified.
 Plague (Yersinia pestis) has historically been treated with it as
the first-line treatment. However streptomycin is approved for
this purpose only by the U.S. Food and Drug Administration. •
 In veterinary medicine, streptomycin is the first-line antibiotic
for use against gram negative bacteria in large animals (horses,
cattle, sheep, etc.). It is commonly combined with procaine
penicillin for intramuscular injection. • Tularemia infections
have been treated mostly with streptomycin.
16
ANTIBIOTICS (CO-1.1)
Neomycine
Neomycin was discovered in 1949 by the
microbiologist Selman Waksman and his student Hubert
Lechevalier at Rutgers University. It is produced naturally by
the bacterium Streptomyces fradiae
Neomycin is an aminoglycoside antibiotic that displays
bactericidal activity against gram-negative aerobic bacilli and
some anaerobic bacilli where resistance has not yet arisen. It is
generally not effective against gram-positive bacilli and
anaerobic gram-negative bacilli. Neomycin comes in oral and
topical formulations, including creams, ointments, and
eyedrops. Neomycin belongs to the aminoglycosid class of
antibiotics that contain two or more amino sugars connected
by glycosidic bonds
16
ANTIBIOTICS (CO-1)
Neomycine
Similar to other aminoglycosides, neomycin has excellent
activity against gram-negative bacteria and is partially
effective against gram-positive bacteria. It is relatively toxic to
humans, with allergic reactions noted as a common adverse
reaction (see: hypersensitivity). Physicians sometimes
recommend using antibiotic ointments without neomycin, such
as Polysporin. The following represents minimum inhibitor
concentration (MIC) susceptibility data for a few medically
significant gram-negative bacteria.s
• Enterobacter cloacae: >16 μg/ml
• Escherichia coli: 1 μg/ml
• Proteus vulgaris: 0.25 μg/ml
16
ANTIBIOTICS (CO-1.1)
Neomycine
In 2005–06, Neomycin was the fifth-most-prevalent allergen
in patch test results (10.0%). It is also a known
GABA gamma-Aminobutyric acid antagonist and can be
responsible for seizures and psychosis. Like other
aminoglycosides, neomycin has been shown to be ototoxic,
causing tinnitus, hearing loss, and vestibular problems in a
small number of patients. Patients with existing tinnitus or
sensorineural hearing loss are advised to speak with a
healthcare practitioner about the risks and side effects prior to
taking this medicatio
16
ANTIBIOTICS (CO-1.1)
Neomycine
Neomycin is typically applied as a topical preparation, such as
Neosporin (neomycin/polymyxin B/bacitraci). The antibiotic
can also be administered orally, in which case it is usually
combined with other antibiotics. Neomycin is not absorbed
from the gastrointestinal tract and has been used as a
preventive measure for hepatic
encephalopath and hypercholesterolemi. By killing bacteria in
the intestinal tract, Neomycin keeps ammonia levels low and
prevents hepatic encephalopathy, especially
before gastrointestinal surgery.
16
ANTIBIOTICS (CO-1)
16
ANTIBIOTICS (CO-1.2)
Kanamycin
• Kanamycin A, often referred to simply as kanamycin, is
an antibiotic used to treat severe bacterial
infections and tuberculosis. It is not a first line treatment. It is
used by mouth, injection into a vein, or injection into a
muscle. Kanamycin is recommended for short-term use only,
usually from 7 to 10 days. As with most antibiotics, it is
ineffective in viral infections.
• Common side effects include hearing and balance
problems. Kidney problems may also occur. Kanamycin is not
recommended during pregnancy as it may harm the baby. It is
likely safe during breastfeeding. Kanamycin is in
the aminoglycoside family of medications. It works by
blocking the production of proteins that are required for
bacterial survival
16
ANTIBIOTICS (CO-1)
Kanamycin
• Spectrum of activity
• Kanamycin is indicated for short-term treatment of bacterial
infections caused by one or more of the following
pathogens: E. coli, Proteus species (both indole-positive and
indole-negative), Enterobacter aerogene, Klebsiella
pneumoniae, Serratia marcescens, and Acinetobacter species.
In cases of serious infection when the causative organism is
unknown, Kanamycin injection in conjunction with
a penicillin- or cephalosporin-type drug may be given initially
before obtaining results of susceptibility testing.
• Kanamycin does not treat viral infections
16
ANTIBIOTICS (CO-1.1)
Tetracyclines
Tetracyclines are a group of broad-
spectrum antibiotic compounds that have a common basic
structure and are either isolated directly from several species
of Streptomycesbacteria or produced semi-synthetically from
those isolated compounds.Tetracycline molecules comprise a
linear fused tetracyclic nucleus (rings designated A, B, C and
D) to which a variety of functional groups are
attached.Tetracyclines are named for their four ("tetra-")
hydrocarbon rings ("-cycl-") derivation ("-ine"). They are
defined as a subclass of polyketides, having an
octahydrotetracene-2-carboxamide skeleton and are known
as derivatives of polycyclic naphthacene carboxamide.While
all tetracyclines have a common structure, they differ from
each other by the presence of chloride, methyl,
and hydroxyl groups.
16
ANTIBIOTICS (CO-1.1)
Tetracycline
Tetracyclines are growth inhibitors (bacteriostatic) rather
than killers of the infectious agent (bacteriocidal) and are
only effective against multiplying microorganisms. They
are short-acting and passively diffuse through porin
channels in the bacterial membrane. They inhibit protein
synthesis by binding reversibly to the bacterial 30S
ribosomal subunit and preventing the aminoacy
tRNA from binding to the A site of the ribosome. They
also bind to some extent the bacterial 50S ribosomal
subunit and may alter the cytoplasmic
membrane causing intracellular components to leak from
bacterial cells.
16
ANTIBIOTICS (CO-1.1)
TETRACYCLINE MODE OF ACTION
Tetracycline antibiotics are protein synthesis
inhibitors. They inhibit the initiation of translation in
variety of ways by binding to the 30S ribosomal subunit,
which is made up of 16S rRNA and 21 proteins. They
inhibit the binding of aminoacyl-tRNA to the mRNA
translation complex. Some studies have shown that
tetracyclines may bind to both 16S and 23S
rRNAs.Tetracyclines also have been found to
inhibit matrix metalloproteinases. This mechanism does
not add to their antibiotic effects, but has led to extensive
research on chemically modified tetracyclines or CMTs
(like incyclinide) for the treatment
of rosacea, acne, diabetes and various types of neoplasms.
5/8/2024 Chandana majee BP-601T Med.Chem-III Unit-1 16
ANTIBIOTICS (CO-1.1)
5/8/2024 Chandana majee BP-601T Med.Chem-III Unit-1 16
ANTIBIOTICS (CO-1.1)
16
ANTIBIOTICS (CO-1.2)
ANTIBIOTICS (CO-1.1)
OXYTERTACYCLINE
Oxytetracycline is a tetracycline used for treatment of
infections caused by a variety of Gram positive and
Gram negative microorganisms including
Mycoplasma pneumoniae, Pasteurella pestis,
Escherichia coli, Haemophilus influenzae (respiratory
infections), and Diplococcus pneumoniae.
ANTIBIOTICS (CO-1.1)
OXYTERTACYCLINE USES
Oxytetracycline, like other tetracyclines, is used to treat
many infections, both common and rare (see Tetracycline
antibiotics group). Its better absorption profile makes it
preferable to tetracycline for moderately severe acne at a
dosage of 250–500 mg four times a day for usually six to
eight weeks at a time, but alternatives should be sought if
no improvement occurs by three months.
Oxytetracycline is used to treat infections of the respiratory and
urinary tracts, skin, ear, eye and gonorrhoea although its use for such
purposes has declined in recent years due to large increases in
bacterial resistance to this class of drugs. The drug is particularly
useful when penicillins and/or macrolides cannot be used due to
allergy.
ANTIBIOTICS (CO-1.1)
OXYTERTACYCLINE SIDE EFFECTS
Side effects are mainly gastrointestinal and photosensitive
allergic reactions common to the tetracycline antibiotic group.
It can also damage calcium-rich organs, such as teeth and
bones, although this is very rare. It sometimes causes nasal
cavities to erode; quite commonly, the BNF suggests, because
of this, tetracyclines should not be used to treat pregnant or
lactating women and children under 12 except in certain
conditions where it has been approved by a specialist because
there are no obvious substitutes. Candidiasis (thrush) is not
uncommon following treatment with broad-spectrum
antibiotics.
16
ANTIBIOTICS (CO-1.1)
103
AKTU QUESTION PAPER
Question-5: Aminoglycosides are commonly administered with
penicillins in chronic infections i) true ii) false
Question-6Clavulanic acid is example of i) beta lactam antibiotics ii)
aminoglycoside iii) macroliodesiv) beta lactamase inhibitor
Question-7 Third and fourth generation cephalosporins have greater
gram negative activity than first generation cephalosporins i) true ii)
false
174
Daily Quiz
• What are antibiotics, Discuss them in detail?
• What are beta lactam antibiotics.
• What is the difference in the basic structure of penicillins and
cephalosporins .
• What is MOA of tetracyclines.
• Discuss the uses of doxycycline
175
Weekly Assignment
Question-1 :salbactum acid is example of
i) beta lactam antibiotics
ii) ii) aminoglycoside
iii) iii) macroliodes
iv) beta lactamase inhibitor
Question-2: Cephalosporins in structure contains
i) Thaimine
ii)glycose sugar
iii) beta lactam ring
iv) thiazolidine ring
176
MCQ s
Question-3: Which of the above statement is true for cephalosporins
i) they are beta lactam antibiotics
ii) they are divided in different generations
iii) both of the above
iv) none of the above
Question-4 Neomycin is example of
i) macrolides
ii) ii) sulphonamides
iii) iii)biguanides
iv) iv) aminoglycosides False
5/8/2024 Chandana majee BP-601T Med.Chem-III Unit-1 177
MCQ s
• Discuss the structure activity relationship (SAR) of
Penicillins.
• Write the mechanism of action of beta lactam antibiotics
• Give classification of cephalosporins with examples.
• Discuss the mechanism of action and uses of cephalosporins.
• Define and classify aminoglycosides
178
Expected Questions for University
Exam
179
References and Books to be followed
Wilson and Giswold’s Organic medicinal and Pharmaceutical
Chemistry.
Foye’s Principles of Medicinal Chemistry.
Burger’s Medicinal Chemistry, Vol I to IV.
MEDICINAL CHEMISTRY-3 ( RNPD)
• https://www.google.com/
• https://en.wikipedia.org/wiki/Antibiotic
• https://longitudeprize.org/blog-post/overview-antibiotics
• https://www.drugs.com/drug-class/macrolides.html
180

More Related Content

Similar to UNIT-1 ANTIBIOTIC.pptx UNIT 1 B.PHARM 601T

Anil k. tyagi
Anil k. tyagiAnil k. tyagi
Anil k. tyagi
neerjayakult
 
ANTIBIOTICS (Tetracycline)
ANTIBIOTICS (Tetracycline)ANTIBIOTICS (Tetracycline)
ANTIBIOTICS (Tetracycline)
Esam Yahya
 
Bacteriocins - An alternative to antibiotics
Bacteriocins - An alternative to antibioticsBacteriocins - An alternative to antibiotics
Bacteriocins - An alternative to antibiotics
Sakeena Asmi
 
Pharmaceutical microbiology syllabus
Pharmaceutical microbiology syllabusPharmaceutical microbiology syllabus
Pharmaceutical microbiology syllabus
Government Pharmacy College Sajong, Government of Sikkim
 
11_General Clinical Microbiology.pdf
11_General Clinical Microbiology.pdf11_General Clinical Microbiology.pdf
11_General Clinical Microbiology.pdf
Vamsi kumar
 
Lary nel b. abao antibiotics resistance report
Lary nel b. abao antibiotics resistance reportLary nel b. abao antibiotics resistance report
Lary nel b. abao antibiotics resistance report
Obihiro University of Agriculture and Veterinary Medicine
 
3. SCOPE OF MICROBIOLOGY.pptx
3. SCOPE OF MICROBIOLOGY.pptx3. SCOPE OF MICROBIOLOGY.pptx
3. SCOPE OF MICROBIOLOGY.pptx
TitoxKendrickKenny
 
Biotechnology power point.pptx
Biotechnology power point.pptxBiotechnology power point.pptx
Biotechnology power point.pptx
KingslyNdanga1
 
Introduction to Biotechnology.pptx
Introduction to Biotechnology.pptxIntroduction to Biotechnology.pptx
Introduction to Biotechnology.pptx
NakshatraChauhan1
 
antibiotics.ppt
antibiotics.pptantibiotics.ppt
antibiotics.ppt
malti19
 
Traditional drug design
Traditional drug designTraditional drug design
Traditional drug design
Sanchit Dhankhar
 
Therapeutics principles
Therapeutics principlesTherapeutics principles
Therapeutics principles
wilson martin aguero echeverria
 
Production of Antibiotics
Production of AntibioticsProduction of Antibiotics
Production of Antibiotics
Sheikh Mohammad Talha
 
Maitree slides for WCCN2014
Maitree slides for WCCN2014Maitree slides for WCCN2014
Maitree slides for WCCN2014
Maitree Suttajit
 
Introduction to Drug Target Identification
Introduction to Drug Target IdentificationIntroduction to Drug Target Identification
Introduction to Drug Target Identification
Dr. Paulsharma Chakravarthy
 
Antibiotic resistance -aveen omer
Antibiotic resistance -aveen omerAntibiotic resistance -aveen omer
Antibiotic resistance -aveen omer
AveenOmer
 
B sc biotech i fob unit 1 introduction to biotechnology
B sc biotech i fob unit 1 introduction to biotechnologyB sc biotech i fob unit 1 introduction to biotechnology
B sc biotech i fob unit 1 introduction to biotechnology
Rai University
 
Antibiotics-and-spectrum-of-action.pptx
Antibiotics-and-spectrum-of-action.pptxAntibiotics-and-spectrum-of-action.pptx
Antibiotics-and-spectrum-of-action.pptx
AfifaKhan62
 
Antibiotic
AntibioticAntibiotic
Antibiotic
PoojaVishnoi7
 
Industrial microbiology presentation ppt
Industrial microbiology presentation pptIndustrial microbiology presentation ppt
Industrial microbiology presentation ppt
Gedefawwubie
 

Similar to UNIT-1 ANTIBIOTIC.pptx UNIT 1 B.PHARM 601T (20)

Anil k. tyagi
Anil k. tyagiAnil k. tyagi
Anil k. tyagi
 
ANTIBIOTICS (Tetracycline)
ANTIBIOTICS (Tetracycline)ANTIBIOTICS (Tetracycline)
ANTIBIOTICS (Tetracycline)
 
Bacteriocins - An alternative to antibiotics
Bacteriocins - An alternative to antibioticsBacteriocins - An alternative to antibiotics
Bacteriocins - An alternative to antibiotics
 
Pharmaceutical microbiology syllabus
Pharmaceutical microbiology syllabusPharmaceutical microbiology syllabus
Pharmaceutical microbiology syllabus
 
11_General Clinical Microbiology.pdf
11_General Clinical Microbiology.pdf11_General Clinical Microbiology.pdf
11_General Clinical Microbiology.pdf
 
Lary nel b. abao antibiotics resistance report
Lary nel b. abao antibiotics resistance reportLary nel b. abao antibiotics resistance report
Lary nel b. abao antibiotics resistance report
 
3. SCOPE OF MICROBIOLOGY.pptx
3. SCOPE OF MICROBIOLOGY.pptx3. SCOPE OF MICROBIOLOGY.pptx
3. SCOPE OF MICROBIOLOGY.pptx
 
Biotechnology power point.pptx
Biotechnology power point.pptxBiotechnology power point.pptx
Biotechnology power point.pptx
 
Introduction to Biotechnology.pptx
Introduction to Biotechnology.pptxIntroduction to Biotechnology.pptx
Introduction to Biotechnology.pptx
 
antibiotics.ppt
antibiotics.pptantibiotics.ppt
antibiotics.ppt
 
Traditional drug design
Traditional drug designTraditional drug design
Traditional drug design
 
Therapeutics principles
Therapeutics principlesTherapeutics principles
Therapeutics principles
 
Production of Antibiotics
Production of AntibioticsProduction of Antibiotics
Production of Antibiotics
 
Maitree slides for WCCN2014
Maitree slides for WCCN2014Maitree slides for WCCN2014
Maitree slides for WCCN2014
 
Introduction to Drug Target Identification
Introduction to Drug Target IdentificationIntroduction to Drug Target Identification
Introduction to Drug Target Identification
 
Antibiotic resistance -aveen omer
Antibiotic resistance -aveen omerAntibiotic resistance -aveen omer
Antibiotic resistance -aveen omer
 
B sc biotech i fob unit 1 introduction to biotechnology
B sc biotech i fob unit 1 introduction to biotechnologyB sc biotech i fob unit 1 introduction to biotechnology
B sc biotech i fob unit 1 introduction to biotechnology
 
Antibiotics-and-spectrum-of-action.pptx
Antibiotics-and-spectrum-of-action.pptxAntibiotics-and-spectrum-of-action.pptx
Antibiotics-and-spectrum-of-action.pptx
 
Antibiotic
AntibioticAntibiotic
Antibiotic
 
Industrial microbiology presentation ppt
Industrial microbiology presentation pptIndustrial microbiology presentation ppt
Industrial microbiology presentation ppt
 

Recently uploaded

The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
RitikBhardwaj56
 
Smart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICTSmart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICT
simonomuemu
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
Academy of Science of South Africa
 
Life upper-Intermediate B2 Workbook for student
Life upper-Intermediate B2 Workbook for studentLife upper-Intermediate B2 Workbook for student
Life upper-Intermediate B2 Workbook for student
NgcHiNguyn25
 
World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024
ak6969907
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
National Information Standards Organization (NISO)
 
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
IreneSebastianRueco1
 
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPLAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
RAHUL
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Akanksha trivedi rama nursing college kanpur.
 
Walmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdfWalmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdf
TechSoup
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
Advanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docxAdvanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docx
adhitya5119
 
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
GeorgeMilliken2
 
BBR 2024 Summer Sessions Interview Training
BBR  2024 Summer Sessions Interview TrainingBBR  2024 Summer Sessions Interview Training
BBR 2024 Summer Sessions Interview Training
Katrina Pritchard
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
TechSoup
 
Cognitive Development Adolescence Psychology
Cognitive Development Adolescence PsychologyCognitive Development Adolescence Psychology
Cognitive Development Adolescence Psychology
paigestewart1632
 
The basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptxThe basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptx
heathfieldcps1
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
History of Stoke Newington
 
A Independência da América Espanhola LAPBOOK.pdf
A Independência da América Espanhola LAPBOOK.pdfA Independência da América Espanhola LAPBOOK.pdf
A Independência da América Espanhola LAPBOOK.pdf
Jean Carlos Nunes Paixão
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
amberjdewit93
 

Recently uploaded (20)

The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
 
Smart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICTSmart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICT
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
 
Life upper-Intermediate B2 Workbook for student
Life upper-Intermediate B2 Workbook for studentLife upper-Intermediate B2 Workbook for student
Life upper-Intermediate B2 Workbook for student
 
World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
 
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
 
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPLAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
 
Walmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdfWalmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdf
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
Advanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docxAdvanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docx
 
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
 
BBR 2024 Summer Sessions Interview Training
BBR  2024 Summer Sessions Interview TrainingBBR  2024 Summer Sessions Interview Training
BBR 2024 Summer Sessions Interview Training
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
 
Cognitive Development Adolescence Psychology
Cognitive Development Adolescence PsychologyCognitive Development Adolescence Psychology
Cognitive Development Adolescence Psychology
 
The basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptxThe basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptx
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
 
A Independência da América Espanhola LAPBOOK.pdf
A Independência da América Espanhola LAPBOOK.pdfA Independência da América Espanhola LAPBOOK.pdf
A Independência da América Espanhola LAPBOOK.pdf
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
 

UNIT-1 ANTIBIOTIC.pptx UNIT 1 B.PHARM 601T

  • 1. IIMT College of Pharmacy, Greater Noida Antibiotic Ms. Bharti Chauhan (ASSISTANT PROFESSOR) Unit: I Subject Name- Medicinal Chemistry-III BP-601T B Pharm VI Sem
  • 2. UNIT – I Antibiotic 08 Hours Antibiotics Historical background, Nomenclature, Stereochemistry, Structure activity relationship, Chemical degradation classification and important products of the following classes. β-Lactam antibiotics: Penicillin, Cepholosporins, β- Lactamase inhibitors, Monobactams Aminoglycosides: Streptomycin, Neomycin, Kanamycin Tetracyclines: Tetracycline, Oxytetracycline, Chlortetracycline, Minocycline, Doxycycline SYLLABUS
  • 3. • Introduction • Introduction of antibiotics. • Classification and mode of action β-Lactam antibiotics • Introduction of synthetic antifungal agents • Classification and mode of Penicillin, Cepholosporins, β- Lactamase inhibitors, Monobactams • Structure activity relationship of β-Lactam antibiotics • Introduction of Aminoglycosides: Streptomycin, Neomycin, Kanamycin Tetracyclines. • Tetracycline, Oxytetracycline, Chlortetracycline, Minocycline, Doxycycline 3 CONTENT
  • 4. Upon completion of the course student shall be able to 1. Understand the importance of drug design and different techniques of drug design. 2. Understand the chemistry of drugs with respect to their biological activity. 3. Know the metabolism, adverse effects and therapeutic value of drugs. 4. Know the importance of SAR of drugs. 4 COURSE OBJECTIVE
  • 5. 5 COURSE OUTCOME CO No. CO STATEMENT LEVEL OF TAXONOMY CO1.1 History and Different types of antibiotics. Level I (Remembering) CO1.2 Mode and action and structure activity relationship of β-Lactam antibiotics Level II (Understanding) CO1.3 Use and adverse effect of β- Lactam antibiotics . Level III (Applying) After completion of this unit it is expected that students will be able to
  • 6. 6 PROGRAMME OUTCOMES (POs) PO 1 Pharmacy Knowledge: Possess knowledge and comprehension of the core and basic knowledge associated with the profession of pharmacy, including biomedical sciences; pharmaceutical sciences; behavioral, social, and administrative pharmacy sciences; and manufacturing practices. PO 2 Planning Abilities: Demonstrate effective planning abilities including time management, resource management, delegation skills and organizational skills. Develop and implement plans and organize work to meet deadlines PO 3 Problem analysis: Utilize the principles of scientific enquiry, thinking analytically, clearly and critically, while solving problems and making decisions during daily practice. Find, analyze, evaluate and apply information systematically and shall make defensible decisions. PO 4 Modern tool usage: Learn, select, and apply appropriate methods and procedures, resources, and modern pharmacy-related computing tools with an understanding of the limitations.
  • 7. 7 PROGRAMME OUTCOMES (POs) PO 5 Leadership skills: Understand and consider the human reaction to change, motivation issues, leadership and team-building when planning changes required for fulfillment of practice, professional and societal responsibilities. Assume participatory roles as responsible citizens or leadership roles when appropriate to facilitate improvement in health and wellbeing. PO 6 Professional Identity: Understand, analyze and communicate the value of their professional roles in society (e.g. health care professionals, promoters of health, educators, managers, employers, employees). PO 7 Pharmaceutical Ethics: Honour personal values and apply ethical principles in professional and social contexts. Demonstrate behavior that recognizes cultural and personal variability in values, communication and lifestyles. Use ethical frameworks; apply ethical principles while making decisions and take responsibility for the outcomes associated with the decisions.
  • 8. 8 PROGRAMME OUTCOMES (POs) PO 8 Communication: Communicate effectively with the pharmacy community and with society at large, such as, being able to comprehend and write effective reports, make effective presentations and documentation, and give and receive clear instructions. PO 9 The Pharmacist and society: Apply reasoning informed by the contextual knowledge to assess societal, health, safety and legal issues and the consequent responsibilities relevant to the professional pharmacy practice PO 10 Environment and sustainability: Understand the impact of the professional pharmacy solutions in societal and environmental contexts, and demonstrate the knowledge of, and need for sustainable development PO 11 Life-long learning: Recognize the need for, and have the preparation and ability to engage in independent and life-long learning in the broadest context of technological change. Self access and use feedback effectively from others to identify learning needs and to satisfy these needs on an ongoing basis.
  • 9. 9 CO-PO MAPPING The CO-PO mapping has been done with correlation levels of 3, 2, 1 and ‘-‘. The notation of 3, 2 and 1 denotes substantially (high), moderately (medium) and slightly (low). The meaning of ‘-‘is no correlation between CO and PO. PO PO 1 PO 2 PO3 PO 4 PO 5 PO6 PO7 PO8 PO9 PO 10 PO 11 CO1.1 3 - 1 3 - - - - 1 - - CO1.2 3 - 1 3 - - - - 1 - - CO1.3 3 - 1 3 - - - - 1 - -
  • 10. 10 Topic Objective mapping with CO Name of Topic Objective of topic Mapping with CO Antibiotic β-Lactam antibiotics Aminoglycosides Tetracycline, Introduction, Mechanism Of Action of β-Lactam antibiotics Aminoglycosides Tetracycline Antibiotic CO1.1 Classificaion Classify the β-Lactam antibiotics Aminoglycosides Tetracycline Antibiotic CO1.2 Synthesis and SAR Structure activity relationship and Synthesis of β-Lactam antibiotics Aminoglycosides Tetracycline Antibiotic CO1.3 • Mapping of Course Outcomes with Topic:
  • 11. • Subject covers pharmacology of various diseases and chemistry of drugs along with SAR and their uses. • Student must have the knowledge of pharmacology of discussed diseases before going to chemistry of drugs used for the same. 11 ANTIBIOTICS (CO-1.1)
  • 12. Antibiotic: Substances derived from a microorganism or produced synthetically, that destroys or limits the growth of a living organism  A drug used to treat bacterial infections.  Antibiotics have no effect on viral infections.  Originally, an antibiotic was a substance produced by one microorganism that selectively inhibits the growth of another.  Synthetic antibiotics, usually chemically related to natural antibiotics, have since been produced that accomplish comparable tasks. 12 ANTIBIOTICS (CO-1.1)
  • 13. Classification of antibiotics • Sources 1. Natural a. Fungi – penicillin, griseofulvin b. Bacteria – Bacillus sp. (polymixin, bacitracin) ; Actinomycetes (tetracycline, chloramphenicol, streptomycin) 2. Synthetic 13 ANTIBIOTICS (CO-1)
  • 14. 15 ANTIBIOTICS (CO-1.1) History of Antibiotics (continue ..) • Antibiotics have been used for millennia to treat infections, although until the last century or so people did not know the infections were caused by bacteria • Various molds and plant extracts were used to treat infections by some of the earliest civilizations – the ancient Egyptians, for example, applied moldy bread to infected wounds • It wasn’t until the late 19th century that scientists began to observe antibacterial chemicals in action. Paul Ehrlich, a German physician, noted that certain chemical dyes colored some bacterial cells but not others. He concluded that, according to this principle, it must be possible to create substances that can kill certain bacteria selectively without harming other cells
  • 15. 15 ANTIBIOTICS (CO-1.1) History of Antibiotics (continue ..) • In 1909, he discovered that a chemical called arsphenamine was an effective treatment for syphilis. • This became the first modern antibiotic, although Ehrlich himself referred to his discovery as 'chemotherapy' – the use of a chemical to treat a disease • The word 'antibiotics' was first used over 30 years later by the Ukrainian-American inventor and microbiologist Selman Waksman, who in his lifetime discovered over 20 antibiotics.
  • 16. 15 ANTIBIOTICS (CO-1.1) History of Antibiotics (continue ..) • Alexander Fleming was, it seems, a bit disorderly in his work and accidentally discovered penicillin. • Upon returning from a holiday in Suffolk in 1928, he noticed that a fungus, Penicillium notatum, had contaminated a culture plate of Staphylococcus bacteria he had accidentally left uncovered. • The fungus had created bacteria-free zones wherever it grew on the plate. • Fleming isolated and grew the mold in pure culture. • He found that P. notatum proved extremely effective even at very low concentrations, preventing Staphylococcus growth even when diluted 800 times, and was less toxic than the disinfectants used at the time..
  • 17. 15 ANTIBIOTICS (CO-1.1) • After early trials in treating human wounds, collaborations with British pharmaceutical companies ensured that the mass production of penicillin (the antibiotic chemical produced by P. notatum) was possible. • Following a fire in Boston, Massachusetts, USA, in which nearly 500 people died, many survivors received skin grafts which are liable to infection by Staphylococcus. • Treatment with penicillin was hugely successful, and the US government began supporting the mass production of the drug. • By D-Day in 1944, penicillin was being widely used to treat troops for infections both in the field and in hospitals throughout Europe. By the end of World War II, penicillin was nicknamed 'the wonder drug' and had saved many lives.
  • 18. Difference between the bactericidal and bacteriostatic  Tetracyclines  Spectinomycin  Sulphonamides  Macrolides  Chloramphenicol  Trimethoprim Bactericidal Antibiotics  Penicillins  Cephalosporins •  Fluoroquinolones (Ciprofloxacin) •  Glycopeptides (Vancomycin) •  Monobactams  Carbapenems 16 ANTIBIOTICS (CO-1.1) Bacteriostatic Antibiotics
  • 25. Mode action of antibiotics 16 ANTIBIOTICS (CO-1.1) Inhibitors of DNA synthesis Inhibitors of bacterial protein synthesis Inhibitors of bacterial cell wall synthesis Interference with metabolism Impairment of nucleic acids
  • 26. 16 ANTIBIOTICS (CO-1) Inhibitors of DNA synthesis Inhibitors of bacterial protein synthesis Inhibitors of bacterial cell wall synthesis Interference with metabolism Impairment of nucleic acids
  • 33. 16 ANTIBIOTICS (CO-1.2) β-lactam antibiotics (beta-lactam antibiotics) are antibiotics that contain a beta-lactam ring in their molecular structure. This includes penicillin derivatives (penams), cephalosporins (cephems), monobactams, carbapenems and carbacephe
  • 35. Penicillin 16 ANTIBIOTICS (CO-1) Penicillin is a secondary metabolite produced by certain bacteria, which is used an antibiotic . A bacterial infection is caused by millions of tiny bacteria that are trying to survive and in multiply the body . An antibiotic attacks and kill these bacteria .  Before the development of penicillin , many people suffered and died from bacterial infections that are no longer considered dangerous today
  • 36. 16 ANTIBIOTICS (CO-1.1) HISTORY 1928 – ALEXANDER FLEMING Bread mold (Penicillium notatum) growing on petri dish 1939 – FLOREY , Chain, and Associates Began work on isolating and synthesizing large amounts of penicillin. 1941 – Introduced in antibacterial therapy 1944 – penicillin has been at the disposal of all people History ALEXANDER FLEMING PROPERTIES Optically active Soluble in water.  Acid resistant. Hydrolyzed by hot inorganic acid .  Effective in treatment of respiratory track infection .
  • 37. 16 ANTIBIOTICS (CO-1.1) Clasification 1.Natural penicillin's  penicillin G Penicillin VK 2.Beta lactase resistant penicillin's 3.Aminopenicillins penicillin G Penicillin VK Methicillin nafcillin Ampicillin amoxicillin 4.Carboxypenicillins 5.Ureidopenicillins 6.penicillin/inihibitor combination Carcenicillin ticarcillin Mezlocillin piperacillin Ampicillin/sulbactam Ticarcillin/clavulanate
  • 40. 16 ANTIBIOTICS (CO-1) PenicillinV (Phenoxymethylpenicillin) Effective Against: • Gram positive + Less effective against Gram negative bacteria Treatment For: • Tonsillitis • Anthrax • Rheumatic fever • Streptococcal skin infections Characteristics: • Narrow spectrum • Should be given orally • Prone to beta-lactamase Penicillin G (Benzylpenicillin) Narrow spectrum antibiotic. Primarily to gram positive bacteria and few others, active agains, Cocci-Streptococci (except group D), Staph.aureus ; gram negative N.gonorrheoe and
  • 41. 16 ANTIBIOTICS (CO-1.1) What is the difference between penicillin G and penicillin V? Penicillin G is a natural penicillin that is produced directly from fermentation of Penicillium crysogenum. Penicillin V is a derivative of penicillin G and because of similarities in spectrum of activity, is considered a natural penicillin. Penicillin G benzathine, potassium, procaine and sodium are currently available in the United States in parenteral formulations for intravenous or intramuscular use. Penicillin V potassium (also called phenoxymethyl penicillin) is a more acid stable and can be administered orally.
  • 56. SAR OF PENICILLI 5/8/2024 Chandana majee BP-601T Med.Chem-III Unit-1 16 ANTIBIOTICS (CO-1.1)
  • 59. ANTIBIOTICS (CO-1.3) MECHANISM OF ACTION OF PENICILLIN Penicillin and other antibiotics in the beta-lactam family contain a characteristic four-membered beta-lactam ring. Penicillin kills bacteria through binding of the beta-lactam ring to DD- transpeptidase, inhibiting its cross-linking activity and preventing new cell wall formation. Without a cell wall, a bacterial cell is vulnerable to outside water and molecular pressures, which causes the cell to quickly die. Since human cells do not contain a cell wall, penicillin treatment results in bacterial cell death without affecting human cells. Gram-positive bacteria have thick cell walls containing high levels of peptidoglycan, while gram- negative bacteria are characterized by thinner cell walls with low levels of peptidoglycan. The cell walls of gram-negative bacteria are surrounded by a lipopolysaccharide (LPS) layer that prevents antibiotic entry into the cell. Therefore, penicillin is most effective against gram- positive bacteria where DD-transpeptidase activity is highest.
  • 60. ANTIBIOTICS (CO-1.3) Nomenclature (a) There are two types of numbering for the fused bicycling system of penicillin: whether which atom is number one Sulfur or Nitrogen. (b) Penam nucleus is used in naming which comprise bicyclic system with the amide carbonyl group. Penicillin is named as 6-acylamino- 2,2-dimethylpenam-3-carboxylic acid. (c) Penicillanic acid nucleus: Which includes the 2,2-dimethyl and 3- carboxyl groups. Penicillin is named as 6- carbonylaminopenicillanic acid. (d) Penicillin nucleus: Which includes 6-carbonyl aminopenicillanic acid. So Penicillin G is named benzylpenicillin if R is benzene ring
  • 67. ANTIBIOTICS (CO-1.3) Stereochemistry (a) The penicillin molecule contains three chiral carbon atoms at C-3, C-5 and C-6 (b) All natural and synthetic penicillins have the same absolute configuration about these three centers (c) The 6 carbon atom bearing the acyl amino group has the L-configuration, whereas the carbon to which the carboxyl group was attached has the D- configuration. (d) The acyl amino group and carboxyl group are trans to each other, with the former and latter in the β orientation relative to penam ring. (e) The absolute stereochemistry of the penicillins is designated as 35: 5R: 6R. (f) The atoms composing the 6-aminopenicillanic acid are biosynthetically derived from two amino acids, Lcysteine and D-valine
  • 79. 16 ANTIBIOTICS (CO-1.1) β- Lactamase enzyme Beta-lactamases are enzymes produced by bacteria that provide multi- resistance to β-lactam antibiotics such as penicillins, cephalosporins, cephamycins, and carbapenems (ertapenem), although carbapenems are relatively resistant to beta-lactamase. In Gram-negative bacteria, β-lactamase enzymes that hydrolyze the amide bond of the four-membered β-lactam ring are the primary resistance mechanism,
  • 80. 16 ANTIBIOTICS (CO-1.1) β- Lactamase inhibitors: Beta-lactamases are a family of enzymes involved in bacterial resistance to beta-lacta antibiotics. They act by breaking the beta-lactam ring that allows penicillin-like antibiotics to work. Beta-lactamase enzymes are produced by certain strains of the followingbacteria: Bacteroides species, Enterococcus species, Hemo philus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae, and Staphylococcus species, either constitutively or on exposure to antimicrobials. Beta-lactamases cleave the beta-lactam ring of susceptible penicillins and cephalosporins, inactivating the antibiotic. Some antimicrobials (eg, cefazolin and cloxacillin) are naturally resistant to certain beta-lactamases.
  • 81. 16 ANTIBIOTICS (CO-1.1) β- Lactamase inhibitors: Clavulanic acid contains a beta-lactam ring and binds strongly to beta-lactamase at or near its active site, thereby hindering enzymatic activity. This protects other beta-lactam antibiotics from beta-lactamase catalysis, thereby enhancing their antibacterial effects.
  • 82. Chandana majee BP-601T Med.Chem-III Unit-1 16 ANTIBIOTICS (CO-1.1) 5/8/2024 β- Lactamase inhibitors: Clavulanic acid contains a beta-lactam ring and binds strongly to beta-lactamase at or near its active site, thereby hindering enzymatic activity. This protects other beta-lactam antibiotics from beta-lactamase catalysis, thereby enhancing their antibacterial effects.
  • 83. Chandana majee BP-601T Med.Chem-III Unit-1 16 ANTIBIOTICS (CO-1.1) 5/8/2024 β- Lactamase inhibitors: Clavulanic acid contains a beta-lactam ring and binds strongly to beta-lactamase at or near its active site, thereby hindering enzymatic activity. This protects other beta-lactam antibiotics from beta-lactamase catalysis, thereby enhancing their antibacterial effects.
  • 84. 16 ANTIBIOTICS (CO-1.1) β- Lactamase inhibitors: Clavulanic acid contains a beta-lactam ring and binds strongly to beta-lactamase at or near its active site, thereby hindering enzymatic activity. This protects other beta-lactam antibiotics from beta-lactamase catalysis, thereby enhancing their antibacterial effects.
  • 85. 16 ANTIBIOTICS (CO-1.1) β- Lactamase inhibitors: Clavulanic acid contains a beta-lactam ring and binds strongly to beta-lactamase at or near its active site, thereby hindering enzymatic activity. This protects other beta-lactam antibiotics from beta-lactamase catalysis, thereby enhancing their antibacterial effects.
  • 86. 16 ANTIBIOTICS (CO-1.1) Clavulanic acid Clavulanic Acid is a semisynthetic beta- lactamase inhibitor isolated from Streptomyces. Clavulanic acid contains a beta-lactam ring and binds strongly to beta- lactamase at or near its active site, thereby hindering enzymatic activit : .
  • 87. 16 ANTIBIOTICS (CO-1.1) Clavulanic acid Clavulanic Acid is a semisynthetic beta- lactamase inhibitor isolated from Streptomyces. Clavulanic acid contains a beta-lactam ring and inds strongly to beta- lactamase at or near its active site, thereby hindering enzymatic activit : .
  • 88. 16 ANTIBIOTICS (CO-1.1) Clavulanic acid The combination of amoxicillin and clavulanic acid is used to treat certain infections caused by bacteria, including infections of the ears, lungs, sinus, skin, and urinary tract. Amoxicillin is in a class of medications called penicillin-like antibiotics. It works by stopping the growth of bacteria. .
  • 89. 16 ANTIBIOTICS (CO-1.2) β- Lactamase inhibitors Bactericidal Act by acylation Clavulanic acid, sulbactam, and tazobactam Avibactam, vaborbactam, and relebactam
  • 95. 16 β-LACTAM ANTIBIOTICS (CO-1.1) • The cephalosporins were isolated from the fungus Cephalosporium acremonium in 1948 by Pro Tzu, Newton, and Abraham (1953) • Cephalosporins contain dihydrothiazine ring, while penicillin contains a tetrahydrothiazole (thiazolidine) ring • The cephalosporins are much more acid stable than the corresponding penicillins. • Cephalosporins can be divided into three classes: 1. Cephalosporin N: penicillin-like structure - a derivative of 6- aminopenicillanic acid. 2. Cephalosporin P: An acidic antibiotic, which is steroidal in nature 3. Cephalosporin-C: It is a true cephalosporin and it is a derivative of 7 amino-cephalosporanic acid – semi synthetic derivatives Cephalosporins
  • 96. 16 β-LACTAM ANTIBIOTICS (CO-1.1) Cephalosporins • Cepham is the name given to the unsubstituted bicyclic lactam.
  • 97. 16 β-LACTAM ANTIBIOTICS (CO-1.1) Classification Cephalosporins (Route of administration) a. Orally administered: cephalexin, cephradine, and cefaclor b. Parentrally administered: cephalothin, cephapirin, cephacetrile, and cefazedone. These agents are sensitive to β-lactamase c. Resistant to β-lactamase and parentrally administered: cefuroxime, cefamandole, cefoxitin d. Metabolically unstable: cephalothin and cephapirin
  • 98. 16 β-LACTAM ANTIBIOTICS (CO-1.1) • First generation cephalosporins - Cephalexin, cephadroxil, cephradine and cephalothine • Second-generation cephalosporins - Cefaclor, cefamandole • Third-generation cephalosporins – Cefotaxime, ceftizoxime • Fourth generation – Cefepime, Cefpirome
  • 99. 16 β-LACTAM ANTIBIOTICS (CO-1.1) Degradation of cephalosporins In prescence of strong acids - inactive lactone
  • 100. 16 β-LACTAM ANTIBIOTICS (CO-1.1) SAR of cephalosporins 1. 7-Acylamino substituents: (i) Acylation of amino group generally increases the potency against gram- positive bacteria, but decreases gram-negative potency. (ii) Substituents on the aromatic ring that increases lipophilicity provide higher gram- positive activity and generally lower gram-negative activity. (iii) The phenyl ring in the side-chain can be replaced with other heterocycles with improved spectrum of activity and pharmacokinetic properties, and these include thiophene, tetrazole, furan, pyridine
  • 101. 16 β-LACTAM ANTIBIOTICS (CO-1.1) SAR of cephalosporins • 2. C-3 substituents: • influences pharmacokinetic and pharmacological properties as well as antibacterial activity. Modification at C-3 position has been made to reduce the degradation of cephalosporins. (i) The benzoyl ester - improved gram-positive activity but lower gram-negative activity. (ii) Pyridine and imidazole- show improved activity against P. aeruginosa. • azide ion with relatively low gram-negative activity. (iii) aromatic thiols of 3-acetoxy group results in an enhancement of activity against gram-negative bacteria with improved pharmacokinetic properties. (iv) Replacement of acetoxy group at C-3 position with —CH3, Cl has resulted in orally active compounds.
  • 102. 16 β-LACTAM ANTIBIOTICS (CO-1.1) SAR of cephalosporins 3. Introduction of C-7 α-methoxy group shows higher resistance to hydrolysis by β-lactamases 4. Oxidation of ring sulphur to sulphoxide or sulphone greatly diminishes or destroys the antibacterial activity. 5. Replacement of sulphur with oxygen leads to oxacepam with increased antibacterial activity, with methylene group - greater chemical stability and a longer half-life. 6. The carboxyl group of position-4 has been converted into ester prodrugs to increase bioavailability of cephalosporins, and these can be given orally as well. Examples include cefuroxime axetil and cefodoxime proxetil. 7. Olefinic linkage at C 3-4 is essential for antibacterial activity. Isomerization of the double bond to 2-3 position leads to great losses in antibacterial activity
  • 103. 16 β-LACTAM ANTIBIOTICS (CO-1.1) Nomenclature of cephalosporins a) The chemical nomenclature of the cephalosporins is slightly more complex than even that of the penicillins because of the presence of a double bond in the dihydrothiazine ring. b) The fused ring system is designated by Chemical Abstracts as 5- thia-1-azabicyclo[4.2.0]oct-2-ene. c) In this system, cephalothin is 3-(acetoxymethyl)-7-[2- (thienylacetyl)amino]-8-oxo-5-thia-1- azabicyclo[4.2.0]oct-2-ene- 2-carboxylic acid.
  • 104. 16 β-LACTAM ANTIBIOTICS (CO-1.1) Monobactams Monobactams are monocyclic and bacterially-produced β-lactam antibiotics. The β-lactam ring is not fused to another ring, in contrast to most other β-lactams. Monobactams are effective only against aerobic Gram-negative bacteria (e.g., Neisseria, Pseudomonas)
  • 106. 16 ANTIBIOTICS (CO-1.1) Monobactams They are resistant to β-lactamases and active against aerobic gram- negative rods. They have no activity against gram-positive bacteria or anaerobes. Aztreonam is the only commercially available monobactam. It is administered either IV or IM and can accumulate in patients with renal failure. Relatively nontoxic, but it may cause phlebitis, skin rash, and, occasionally, abnormal liver function tests. Penicillin-allergic patients tolerate aztreonam without reaction. Monobactams have monocyclic beta lactam ring and are resistant to beta lactamse
  • 107. Aminoglycosides Aminoglycosides are a class of antibiotics used to treat serious infections caused by bacteria that either multiply very quickly or are difficult to treat. Aminoglycosides are called bactericidal antibiotics because they kill bacteria directly. 16 ANTIBIOTICS (CO-1.1)
  • 108. Aminoglycosides Aminoglycosides display concentration-dependent bactericidal activity against "most gram-negative aerobic and facultative anaerobic bacilli" but not against gram-negative anaerobes and most gram-positive bacteria. They require only short contact time and are most effective against susceptible bacterial populations that are rapidly multiplying. 16 ANTIBIOTICS (CO-1.1) NH2 N H2
  • 111. SAR OF AMINIGLYCOSIDE 16 ANTIBIOTICS (CO-1) 6 amino group increses the activity 6 amino group replace by OH decreases the activity 2 amino group increses the activity 1 2 Acetylating retain the activity
  • 113. 16 ANTIBIOTICS (CO-1.1) AMINOGYCOSIDE AMINO + GYCOSIDE Polybasic amino groups linked glycosidically to two or more aminosugar.
  • 117. Amino Glycoside MOA 16 ANTIBIOTICS (CO-1.3) Aminogycoside are polar so they can not penetrate the peptidoglycan layer Amino glycoside Amino glycoside
  • 118. ANTIBIOTICS (CO-1.3) Aminogycoside are polar so they can not penetrate the peptidoglycan layer Amino glycoside Amino glycoside
  • 119. Streptomycin Streptomycin is an antibiotic medication used to treat a number of bacterial infections Streptomycin was discovered in 1943 by Albert Schatz from Streptomyces griseus. It is on the World Health Organization's List of Essential Medicines. 16 ANTIBIOTICS (CO-1.1)
  • 120. Streptomycin 5/8/2024 Chandana majee BP-601T Med.Chem-III Unit-1 16 ANTIBIOTICS (CO-1.3) O O OH OH N NH H2N HO N H2N NH2 O O OH OH OH HN O OH N Methyl –L- glucosamine L -sterptose Streptidine
  • 121. Streptomycin Streptomycin is an antibiotic medication used to treat a number of bacterial infections Streptomycin was discovered in 1943 by Albert Schatz from Streptomyces griseus. It is on the World Health Organization's List of Essential Medicines. 16 ANTIBIOTICS (CO-1.1)
  • 122. Streptomycin • Streptomycin, like other aminoglycosidic antibiotics (e.g., gentamycin, neomycin, kanamycin, tobramycin), inhibits protein synthesis in bacterial cells by binding to the 30S subunit of ribosomes. • By doing so, the streptomycin causes a structural change which interferes with the recognition site of codon-anticodon interaction resulting in misreading of the genetic message carried by messenger RNA (mRNA). The mechanism of inhibition of protein synthesis by streptomycin is schematically shown in 16 ANTIBIOTICS (CO-1.1)
  • 124. Streptomycin  Infective endocarditis caused by enterococcus when the organism is not sensitive to gentamicin  Tuberculosis in combination with other antibiotics. For active tuberculosis it is often given together with isoniazid, rifampicin, and pyrazinamide.  It may be useful in cases where resistance to other drugs is identified.  Plague (Yersinia pestis) has historically been treated with it as the first-line treatment. However streptomycin is approved for this purpose only by the U.S. Food and Drug Administration. •  In veterinary medicine, streptomycin is the first-line antibiotic for use against gram negative bacteria in large animals (horses, cattle, sheep, etc.). It is commonly combined with procaine penicillin for intramuscular injection. • Tularemia infections have been treated mostly with streptomycin. 16 ANTIBIOTICS (CO-1.1)
  • 125. Neomycine Neomycin was discovered in 1949 by the microbiologist Selman Waksman and his student Hubert Lechevalier at Rutgers University. It is produced naturally by the bacterium Streptomyces fradiae Neomycin is an aminoglycoside antibiotic that displays bactericidal activity against gram-negative aerobic bacilli and some anaerobic bacilli where resistance has not yet arisen. It is generally not effective against gram-positive bacilli and anaerobic gram-negative bacilli. Neomycin comes in oral and topical formulations, including creams, ointments, and eyedrops. Neomycin belongs to the aminoglycosid class of antibiotics that contain two or more amino sugars connected by glycosidic bonds 16 ANTIBIOTICS (CO-1)
  • 126. Neomycine Similar to other aminoglycosides, neomycin has excellent activity against gram-negative bacteria and is partially effective against gram-positive bacteria. It is relatively toxic to humans, with allergic reactions noted as a common adverse reaction (see: hypersensitivity). Physicians sometimes recommend using antibiotic ointments without neomycin, such as Polysporin. The following represents minimum inhibitor concentration (MIC) susceptibility data for a few medically significant gram-negative bacteria.s • Enterobacter cloacae: >16 μg/ml • Escherichia coli: 1 μg/ml • Proteus vulgaris: 0.25 μg/ml 16 ANTIBIOTICS (CO-1.1)
  • 127. Neomycine In 2005–06, Neomycin was the fifth-most-prevalent allergen in patch test results (10.0%). It is also a known GABA gamma-Aminobutyric acid antagonist and can be responsible for seizures and psychosis. Like other aminoglycosides, neomycin has been shown to be ototoxic, causing tinnitus, hearing loss, and vestibular problems in a small number of patients. Patients with existing tinnitus or sensorineural hearing loss are advised to speak with a healthcare practitioner about the risks and side effects prior to taking this medicatio 16 ANTIBIOTICS (CO-1.1)
  • 128. Neomycine Neomycin is typically applied as a topical preparation, such as Neosporin (neomycin/polymyxin B/bacitraci). The antibiotic can also be administered orally, in which case it is usually combined with other antibiotics. Neomycin is not absorbed from the gastrointestinal tract and has been used as a preventive measure for hepatic encephalopath and hypercholesterolemi. By killing bacteria in the intestinal tract, Neomycin keeps ammonia levels low and prevents hepatic encephalopathy, especially before gastrointestinal surgery. 16 ANTIBIOTICS (CO-1)
  • 130. Kanamycin • Kanamycin A, often referred to simply as kanamycin, is an antibiotic used to treat severe bacterial infections and tuberculosis. It is not a first line treatment. It is used by mouth, injection into a vein, or injection into a muscle. Kanamycin is recommended for short-term use only, usually from 7 to 10 days. As with most antibiotics, it is ineffective in viral infections. • Common side effects include hearing and balance problems. Kidney problems may also occur. Kanamycin is not recommended during pregnancy as it may harm the baby. It is likely safe during breastfeeding. Kanamycin is in the aminoglycoside family of medications. It works by blocking the production of proteins that are required for bacterial survival 16 ANTIBIOTICS (CO-1)
  • 131. Kanamycin • Spectrum of activity • Kanamycin is indicated for short-term treatment of bacterial infections caused by one or more of the following pathogens: E. coli, Proteus species (both indole-positive and indole-negative), Enterobacter aerogene, Klebsiella pneumoniae, Serratia marcescens, and Acinetobacter species. In cases of serious infection when the causative organism is unknown, Kanamycin injection in conjunction with a penicillin- or cephalosporin-type drug may be given initially before obtaining results of susceptibility testing. • Kanamycin does not treat viral infections 16 ANTIBIOTICS (CO-1.1)
  • 132. Tetracyclines Tetracyclines are a group of broad- spectrum antibiotic compounds that have a common basic structure and are either isolated directly from several species of Streptomycesbacteria or produced semi-synthetically from those isolated compounds.Tetracycline molecules comprise a linear fused tetracyclic nucleus (rings designated A, B, C and D) to which a variety of functional groups are attached.Tetracyclines are named for their four ("tetra-") hydrocarbon rings ("-cycl-") derivation ("-ine"). They are defined as a subclass of polyketides, having an octahydrotetracene-2-carboxamide skeleton and are known as derivatives of polycyclic naphthacene carboxamide.While all tetracyclines have a common structure, they differ from each other by the presence of chloride, methyl, and hydroxyl groups. 16 ANTIBIOTICS (CO-1.1)
  • 133. Tetracycline Tetracyclines are growth inhibitors (bacteriostatic) rather than killers of the infectious agent (bacteriocidal) and are only effective against multiplying microorganisms. They are short-acting and passively diffuse through porin channels in the bacterial membrane. They inhibit protein synthesis by binding reversibly to the bacterial 30S ribosomal subunit and preventing the aminoacy tRNA from binding to the A site of the ribosome. They also bind to some extent the bacterial 50S ribosomal subunit and may alter the cytoplasmic membrane causing intracellular components to leak from bacterial cells. 16 ANTIBIOTICS (CO-1.1)
  • 134. TETRACYCLINE MODE OF ACTION Tetracycline antibiotics are protein synthesis inhibitors. They inhibit the initiation of translation in variety of ways by binding to the 30S ribosomal subunit, which is made up of 16S rRNA and 21 proteins. They inhibit the binding of aminoacyl-tRNA to the mRNA translation complex. Some studies have shown that tetracyclines may bind to both 16S and 23S rRNAs.Tetracyclines also have been found to inhibit matrix metalloproteinases. This mechanism does not add to their antibiotic effects, but has led to extensive research on chemically modified tetracyclines or CMTs (like incyclinide) for the treatment of rosacea, acne, diabetes and various types of neoplasms. 5/8/2024 Chandana majee BP-601T Med.Chem-III Unit-1 16 ANTIBIOTICS (CO-1.1)
  • 135. 5/8/2024 Chandana majee BP-601T Med.Chem-III Unit-1 16 ANTIBIOTICS (CO-1.1)
  • 138. OXYTERTACYCLINE Oxytetracycline is a tetracycline used for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae (respiratory infections), and Diplococcus pneumoniae. ANTIBIOTICS (CO-1.1)
  • 139. OXYTERTACYCLINE USES Oxytetracycline, like other tetracyclines, is used to treat many infections, both common and rare (see Tetracycline antibiotics group). Its better absorption profile makes it preferable to tetracycline for moderately severe acne at a dosage of 250–500 mg four times a day for usually six to eight weeks at a time, but alternatives should be sought if no improvement occurs by three months. Oxytetracycline is used to treat infections of the respiratory and urinary tracts, skin, ear, eye and gonorrhoea although its use for such purposes has declined in recent years due to large increases in bacterial resistance to this class of drugs. The drug is particularly useful when penicillins and/or macrolides cannot be used due to allergy. ANTIBIOTICS (CO-1.1)
  • 140. OXYTERTACYCLINE SIDE EFFECTS Side effects are mainly gastrointestinal and photosensitive allergic reactions common to the tetracycline antibiotic group. It can also damage calcium-rich organs, such as teeth and bones, although this is very rare. It sometimes causes nasal cavities to erode; quite commonly, the BNF suggests, because of this, tetracyclines should not be used to treat pregnant or lactating women and children under 12 except in certain conditions where it has been approved by a specialist because there are no obvious substitutes. Candidiasis (thrush) is not uncommon following treatment with broad-spectrum antibiotics. 16 ANTIBIOTICS (CO-1.1)
  • 142. Question-5: Aminoglycosides are commonly administered with penicillins in chronic infections i) true ii) false Question-6Clavulanic acid is example of i) beta lactam antibiotics ii) aminoglycoside iii) macroliodesiv) beta lactamase inhibitor Question-7 Third and fourth generation cephalosporins have greater gram negative activity than first generation cephalosporins i) true ii) false 174 Daily Quiz
  • 143. • What are antibiotics, Discuss them in detail? • What are beta lactam antibiotics. • What is the difference in the basic structure of penicillins and cephalosporins . • What is MOA of tetracyclines. • Discuss the uses of doxycycline 175 Weekly Assignment
  • 144. Question-1 :salbactum acid is example of i) beta lactam antibiotics ii) ii) aminoglycoside iii) iii) macroliodes iv) beta lactamase inhibitor Question-2: Cephalosporins in structure contains i) Thaimine ii)glycose sugar iii) beta lactam ring iv) thiazolidine ring 176 MCQ s
  • 145. Question-3: Which of the above statement is true for cephalosporins i) they are beta lactam antibiotics ii) they are divided in different generations iii) both of the above iv) none of the above Question-4 Neomycin is example of i) macrolides ii) ii) sulphonamides iii) iii)biguanides iv) iv) aminoglycosides False 5/8/2024 Chandana majee BP-601T Med.Chem-III Unit-1 177 MCQ s
  • 146. • Discuss the structure activity relationship (SAR) of Penicillins. • Write the mechanism of action of beta lactam antibiotics • Give classification of cephalosporins with examples. • Discuss the mechanism of action and uses of cephalosporins. • Define and classify aminoglycosides 178 Expected Questions for University Exam
  • 147. 179 References and Books to be followed Wilson and Giswold’s Organic medicinal and Pharmaceutical Chemistry. Foye’s Principles of Medicinal Chemistry. Burger’s Medicinal Chemistry, Vol I to IV. MEDICINAL CHEMISTRY-3 ( RNPD) • https://www.google.com/ • https://en.wikipedia.org/wiki/Antibiotic • https://longitudeprize.org/blog-post/overview-antibiotics • https://www.drugs.com/drug-class/macrolides.html
  • 148. 180